Todd Usen - 12 Dec 2025 Form 4 Insider Report for Adagio Medical Holdings, Inc. (ADGM)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ADGM
Reported as of: 12 Dec 2025
Net transaction value: +$225,973
SEC form: 4
Accepted by SEC: 15 Dec 2025, 21:24:15 UTC
Prior SEC filing: 13 Feb 2025
Next SEC filing: 09 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Deborah Kaster, Attorney-in-Fact

Key filing fact

Todd Usen filed Form 4 for Adagio Medical Holdings, Inc. (ADGM) on 15 Dec 2025.

Key facts

This page summarizes Todd Usen's Form 4 filing for Adagio Medical Holdings, Inc. (ADGM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Dec 2025, 21:24.

Change

Previous filing in this sequence was filed on 13 Feb 2025.
Current net transaction value: +$225,973.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001964615 Primary reporting owner

Usen Todd

Relationship: Chief Executive Officer, Director
Address: C/O ADAGIO MEDICAL HOLDINGS, INC., 26051 MERIT CIRCLE, SUITE 102, LAGUNA HILLS
Signature: /s/ Deborah Kaster, Attorney-in-Fact
Signature date: 15 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADGM transaction

Common Stock

Purchase

Transaction value: $225,973
Shares: +207,315
Change %
Price: $1.09
Shares after: 207,315
Date: 12 Dec 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Open market purchase.

Footnote F2

This transaction was executed in multiple trades at prices ranging from $0.9258 to $1.14101. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.